Prescribing of bicalutamide should be restricted to patients at high risk of disease progression
- 13 Downloads
KeywordsPublic Health Adverse Effect High Risk Prostate Cancer Medicinal Product
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- 1.European Medicines Agency.Questions and answers on bicalutamide 150 mg tablets. Internet Document: [2 pages], 24 May 2007. Available from: URL: http://www.emea.europa.eu
© Adis International limited or Adis Data Information BV 2007